Heartbeam Inc
BEAT1.000USD
-0.020-1.96%
Fechamento 08/04, 16:00（ET）Cotações atrasadas em 15 min
33.73MValor de mercado
PerdaP/L TTM
Mais detalhes de Heartbeam Inc Empresa
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
Informações da empresa
Código da empresaBEAT
Nome da EmpresaHeartbeam Inc
Data de listagemOct 14, 2021
CEOMr. Robert P. (Rob) Eno
Número de funcionários21
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 14
Endereço2118 Walsh Ave., Suite 210
CidadeSANTA CLARA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal95050
Telefone14088994443
Sitehttps://www.heartbeam.com/
Código da empresaBEAT
Data de listagemOct 14, 2021
CEOMr. Robert P. (Rob) Eno
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
911.39K
+0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
244.79K
--
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
129.12K
--
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
17.65K
--
Mr. Kenneth (Ken) Nelson
Mr. Kenneth (Ken) Nelson
Independent Director
Independent Director
--
--
Dr. Michael R. Jaff
Dr. Michael R. Jaff
Independent Director
Independent Director
--
--
Mr. Willem P. Elfrink
Mr. Willem P. Elfrink
Independent Director
Independent Director
--
--
Mr. Mark E. Strome
Mr. Mark E. Strome
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President - MZ North America
Executive Vice President - MZ North America
--
--
Mr. Robert P. (Rob) Eno
Mr. Robert P. (Rob) Eno
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
911.39K
+0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
244.79K
--
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
129.12K
--
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
17.65K
--
Mr. Kenneth (Ken) Nelson
Mr. Kenneth (Ken) Nelson
Independent Director
Independent Director
--
--
Dr. Michael R. Jaff
Dr. Michael R. Jaff
Independent Director
Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Strome Mezzanine Fund, L.P.
9.32%
Schwartzberg (Andrew)
5.62%
Public Ventures LLC
3.15%
Vajdic (Branislav)
2.70%
The Vanguard Group, Inc.
2.43%
Other
76.78%
Investidores
Investidores
Proporção
Strome Mezzanine Fund, L.P.
9.32%
Schwartzberg (Andrew)
5.62%
Public Ventures LLC
3.15%
Vajdic (Branislav)
2.70%
The Vanguard Group, Inc.
2.43%
Other
76.78%
Tipos de investidores
Investidores
Proporção
Corporation
12.47%
Individual Investor
11.68%
Investment Advisor
7.43%
Investment Advisor/Hedge Fund
1.57%
Research Firm
0.04%
Other
66.82%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
72
11.33M
33.52%
+116.07K
2025Q1
73
11.32M
33.47%
+184.21K
2024Q4
67
10.34M
30.80%
-62.00K
2024Q3
67
10.57M
36.60%
-314.36K
2024Q2
63
10.32M
35.80%
-451.58K
2024Q1
59
9.95M
34.92%
-469.47K
2023Q4
60
9.79M
39.69%
+2.93M
2023Q3
56
9.76M
43.96%
+2.51M
2023Q2
53
8.43M
39.17%
+5.45M
2023Q1
36
2.26M
27.56%
-577.08K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Strome Mezzanine Fund, L.P.
3.15M
9.32%
--
--
Mar 31, 2025
Schwartzberg (Andrew)
1.90M
5.62%
--
--
Mar 31, 2025
Public Ventures LLC
1.07M
3.15%
+3.91K
+0.37%
Mar 31, 2025
Vajdic (Branislav)
911.39K
2.7%
+1.29K
+0.14%
Mar 31, 2025
The Vanguard Group, Inc.
823.01K
2.43%
+59.31K
+7.77%
Mar 31, 2025
Elfrink (Willhem P.)
424.81K
1.26%
--
--
Mar 31, 2025
Smith, Salley & Associates, LLC
367.65K
1.09%
+117.65K
+47.06%
Mar 31, 2025
Geode Capital Management, L.L.C.
247.37K
0.73%
+5.53K
+2.29%
Mar 31, 2025
Ferrari (Richard M)
244.79K
0.72%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
203.04K
0.6%
+43.03K
+26.90%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
